Nuclear Medicine: Page 80

Bone scan software predicts prostate cancer survival

By Brian Casey

Researchers using automated software to assess bone scintigraphy scans of patients with metastatic prostate cancer found that the algorithm helped them predict which patients were more likely to survive, compared with manual methods of interpreting the scans, according to a May 17 paper in JAMA Oncology.

May 16, 2018

Immuno-PET tracer offers hope for early cancer treatment

By Wayne Forrest

Researchers are developing a PET radiotracer designed to adhere to and illuminate immune cells in cancer patients. They believe it could offer an earlier look at treatment response compared with tracers such as FDG that focus on cancer cells, according to a study published May 14 in the Journal of Clinical Investigation.

May 16, 2018

Canadian cyclotron could address isotope supply issues

By AuntMinnie.com staff writers

After years of development, researchers at the University of Alberta have succeeded in creating an environmentally friendly cyclotron that can produce enough medical isotopes for as many as 1,000 imaging scans a day.

May 14, 2018

PET with novel tracers foretells early Alzheimer's risk

By Wayne Forrest

Researchers are making strides toward discovering which individuals have an increased risk of Alzheimer's disease thanks to two novel PET radiotracers that show increased uptake in key regions of the brain, according to two studies published online May 14 in JAMA Neurology.

May 14, 2018

PET may help spot protein clumps in heart disease

By AuntMinnie.com staff writers

Using preclinical PET and other techniques, researchers appear to have found a connection between the accumulation of protein clumps and heart failure in mice, according to results published in the May 11 issue of Circulation Research. By visualizing the protein, PET could eventually prove useful for monitoring and treating heart disease in humans, the group believes.

May 10, 2018

Curium to market xenon-133 gas in the U.S.

By AuntMinnie.com staff writers

Global nuclear medicine firm Curium has expanded its U.S. offerings to include xenon-133 gas, sourced from its Petten manufacturing facility in the Netherlands and using low-enriched uranium targets.

May 9, 2018

Blue Earth expands PSMA-PET/CT imaging portfolio

By AuntMinnie.com staff writers

Molecular imaging firm Blue Earth Diagnostics has signed an agreement for exclusive rights to radiopharmaceutical technology firm Scintomic's "radiohybrid" prostate-specific membrane antigen (rhPSMA-7) imaging agent.

May 6, 2018

Novel PET tracer could help assess arthritis

By Wayne Forrest

Researchers from South Korea have developed a novel PET tracer that can be used to visualize joint inflammation in mice and potentially could provide an early diagnosis of rheumatoid arthritis in humans, according to a preclinical study in the Journal of Nuclear Medicine.

May 6, 2018

ACR presents white paper on incidental pituitary findings

By AuntMinnie.com staff writers

The American College of Radiology (ACR) Committee on Incidental Findings has published new guidelines for managing incidental pituitary findings on CT, MRI, and F-18 FDG PET in a white paper in the Journal of the American College of Radiology.

May 3, 2018

Report: Philips to cut more jobs in Cleveland

By AuntMinnie.com staff writers

Philips Healthcare has filed paperwork with the state of Ohio indicating that it plans to cut more jobs at a manufacturing plant in the Cleveland area than the 65 positions it originally announced in February, according to an article on Cleveland.com.

May 3, 2018

Theranostic approach could aid pancreatic cancer patients

By Wayne Forrest

German researchers obtained positive results with a novel diagnostic and therapeutic (theranostic) approach for ductal pancreatic adenocarcinoma used with SPECT/CT, scintigraphy, and PET/CT. Their findings were published in the May issue of the Journal of Nuclear Medicine.

May 2, 2018

PiB-PET study strengthens link between amyloid, dementia

By Wayne Forrest

The presence of amyloid on PET scans may be a sign that adults with no symptoms of dementia are still at risk of mild cognitive impairment or even Alzheimer's disease in the future as they age, according to a study published online April 30 in JAMA Neurology.

April 30, 2018

Previous Page

Page 80 of 440

Next Page